Priority Date: 25.10.11 (IT 2011MO00270)

A MODIFIED EFFECTOR CELL (OR CHIMERIC RECEPTOR) FOR TREATING DISIALOGANGLIOSIDE Gp2-EXPRESSING NEOPLASIA

  • Application ID: EP12813454
  • Status: GRANT OF PATENT INTENDED

Attorneys

no operation time available
1 office
active in Legal Services
no operation time available
2 offices
active in Legal Services

Specialization

This EP application has the IPC class A61, C07, and C12. We found, that TransMIT GmbH, Kailuweit & Uhlemann, Lederer Keller Patentanwälte Partnerschaft mbB, Vossius & Partner Patentanwälte Rechtsanwälte mbB, df-mp Dörries Frank-Molnia & Pohlman, Patentanwälte Rechtsanwälte PartG mbB and 128 others are specialized in this combination either. For a similar patent, they might be a good choice.

Timeline

  • 25.10.2011 - Priority Date (IT 2011MO00270)
  • 02.05.2013 - Publication A1 (WO2013061273)
  • 03.09.2014 - Publication A1 (EP2771355)